Nod for CCMD to take over CCM’s pharmaceutical arm


PETALING JAYA: CCM Duopharma Biotech Bhd (CCMD) has obtained shareholders approval to take over Chemical Co of Malaysia Bhd’s (CCM) pharmaceutical arm in a deal that is valued at RM245.1mil.

The purchase of the six pharmaceutical units from its parent company includes CCM Pharmaceuticals Sdn Bhd, CCM Pharma Sdn Bhd, Innovax Sdn Bhd, Upha Pharmaceutical Manufacturing (M) Sdn Bhd, CCM International (Philippines) Inc and CCM Pharmaceuticals (S) Pte Ltd.

5.5 PAYDAY OFFER: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Business , CCMD , Drugs , Pharmaceuticals

Next In Business News

Ringgit seen to trade within RM3.96-RM3.98 against US dollar next week
Too close for comfort
The invisible M40
Why international families favour KL
Ringgit strength, IMF’s GDP forecast signal global confidence in Malaysia’s economy, says Muhammad Kamil
Calm markets supercharge carry trade
Secondhand luxury sellers go global
Rethinking China manufacturing
DPS jumps on data centre wave
The art of business

Others Also Read